Klinik Atölye

Karaciğer: diffüz ve vasküler hastalıklar · Taklitçi · Düşük öncelik

Arterioportal şant ve geçici hepatik atenüasyon farkı (THAD)

Arterioportal shunt and transient hepatic attenuation difference

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez.

Arterioportal şant ve geçici hepatik atenüasyon farkı (THAD): yayımlanmış olgu görüntüsü, aksiyel kesit

4 adım

Görüntü: Hellerhoff, “Arteriovenoeser Shunt Leber - 63jw - CT axial arteriell und portalvenoes”, Wikimedia Commons · CC BY-SA 3.0. Değişiklik: kırpıldı, yeniden boyutlandırıldı, odak işaretleri eklendi.

Özet

Arterioportal şant, hepatik arter sistemi ile portal venöz sistem arasında bağlantıdır; THAD, bölgesel hepatik arter ve portal venöz kanlanma oranındaki değişikliğe bağlı olarak arteriyel faz BT'de geçici parankim kontrastlanması şeklinde görülür. THAD, arteriyel faz BT'de kama biçimli ve geçici bir hiperatenüasyon alanı olarak görülebilir; arteriyel kanlanma oranının artması bölgesel atenüasyonu yükseltirken portal fazda karaciğer belirgin ve yaygın biçimde kontrastlanır. THAD'ların hipervasküler tümörleri taklit edebileceğini ve küçük arterioportal şantların nodüler görünebileceğini bilmek, görüntülerin daha doğru değerlendirilmesine yardımcı olur. THAD'nin olası nedenleri arasında portal ven akımındaki azalma, arterioportal şant, tümör, apse ve inflamatuvar hastalıklar bulunduğundan, altta yatan anormallikler ayrıca değerlendirilmelidir.

Faz ve pencere

Arteriyel tanısal
Arteriyel fazda geçici hiperatenüasyon alanı görülebilir; portal akım azalması, arterioportal şant veya diğer altta yatan intrahepatik anormallikler araştırılmalıdır.
Portal tanısal
THAD arteriyel faz BT'de geçici kontrastlanma alanı olarak görülür; portal fazda kontrastlanma farkının sürüp sürmediği değerlendirilmelidir.
Gecikmiş
Arterioportal şant alanları denge fazında izoatenü olabilir; bu nedenle arteriyel fazdaki geçici kontrastlanma görünümü diğer fazlarla birlikte değerlendirilmelidir.

Önerilen pencereler: Batın (G 400 / M 50), Karaciğer (G 150 / M 30).

BT bulguları

  • Arteriyel fazda kama, üçgen veya coğrafi şekilli hiperatenüasyon; sıklıkla periferik/subkapsüler dağılım
  • Arterioportal şantlar geçici kama biçimli veya nodüler kontrastlanma alanları oluşturabilir; görünüm özellikle sirotik karaciğerde hipervasküler tümörlerle karışabilir.
  • Portal fazda lezyon benzeri farkın kaybolup çevre parankime yaklaşması
  • Arterioportal şantlar, hipervasküler tümörleri taklit edebilen geçici parankim kontrastlanma alanları oluşturabilir.
  • Arterioportal şantlar ve portal ven akımını azaltan anomaliler THAD'ye yol açabilir; bunların saptanması olası nedeni değerlendirmeye yardımcı olur.
  • Portal dal tıkanıklığı, tümör, inflamasyon veya cerrahi/girişim odağına komşu bölgesel perfüzyon değişikliği

Normalde

Normal dinamik BT’de karaciğer parankimi arteriyel fazda hafif ve görece homojen, portal fazda ise yaygın ve dengeli kontrastlanır. Portal fazda karaciğerin kontrastlanması belirgin ve yaygın hale gelir; arteriyel fazdaki geçici hiperatenüasyonun diğer fazlardaki görünümüyle karşılaştırılması perfüzyon farkını değerlendirmeye yardımcı olur.

Normal BT ile kıyasla

Aynı bölgenin, kaynak veri setinde patoloji içermediği belirtilen bir BT incelemesini kesit kesit kaydırın; organ sınırlarını açarak anatomiyi hasta görüntüsüyle karşılaştırın. Küçük rastlantısal bulgular tümüyle dışlanmamıştır.

Kaynak: TotalSegmentator v2.01 veri seti (Wasserthal ve ark., Radiology: Artificial Intelligence 2023), CC BY 4.0, vaka s0541; organ sınırları veri setinin otomatik segmentasyonundan, birleştirilerek sadeleştirildi. Görüntüler 2,5 mm kesit aralığına yeniden örneklendi.

Ayırıcı tanı

Arterioportal şantlar, özellikle sirotik karaciğerde amorf veya nodüler görünümleri nedeniyle hipervasküler tümörlerle karışabilir.
Karaciğer infarktı
portal fazda kontrastlanmama sürer ve segmental damar dağılımındaki kama silinmez.
Üçüncü giriş etkileri fokal yağlanma veya yağdan korunmuş alanlar gibi yalancı lezyonlara yol açabilir; THAD ise bölgesel hepatik arter ve portal ven kanlanma oranındaki değişiklikle ilişkilidir.
Portal ven dal trombozu
ilgili dalda kalıcı dolum defekti/sonlanma ve ona uyan perfüzyon farkı olabilir; THAD tek başına şantın nedenini göstermez.

Tuzaklar

  • Arteriyel tek fazdaki kama hiperatenüasyonu metastaz veya HCC diye adlandırmayın; portal fazda aynı alanın eşitlenmesini ve damarların içinden geçişini kontrol edin.
  • THAD farklı portal venöz akım bozuklukları, arterioportal şantlar, tümörler, apseler ve inflamatuvar hastalıklarla ilişkili olabilir; olası nedenler ayrıca değerlendirilmelidir.
  • Hepatik arter ve portal ven kontrast bolusunun karaciğere varış zamanları farklı olduğundan, fazlar arası karaciğer kontrastlanması bu zamanlama dikkate alınarak değerlendirilmelidir.

Kendini dene

  1. Arteriyel faz BT'de bölgesel hepatik arter ve portal ven kanlanma oranındaki değişikliğe bağlı geçici parankim kontrastlanma alanına ne ad verilir?

    Cevabı göster

    THAD. Bölgesel arteriyel ve portal venöz kanlanma oranındaki değişiklik, arteriyel faz BT’de geçici bir kontrastlanma alanı oluşturabilir; bu görünüm THAD olarak adlandırılır.

  2. Portal venöz akımın bölgesel azalması, arteriyel faz BT'de hangi geçici karaciğer görünümüne yol açabilir?

    Cevabı göster

    THAD. Portal akım azaldığında, bölgeyi besleyen hepatik arter kanı opaklaşmamış portal kanla seyrelmez; bu nedenle arteriyel fazda fokal atenüasyon artışı görülebilir.

İlgili konular

Kaynaklar

Bu sayfadaki 31 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 22 cümle bu karşılaştırmada düzeltildi (2026-10-09).

  1. Transient Hepatic Attenuation Differences in Computed Tomography from Extrahepatic Portal Vein Compressionpmc.ncbi.nlm.nih.gov
  2. Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.pubmed.ncbi.nlm.nih.gov
  3. Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate.pubmed.ncbi.nlm.nih.gov
  4. Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings.pubmed.ncbi.nlm.nih.gov
  5. Severe Liver Injury Complicated by Portal Hypertension and Traumatic Arterioportal Shunt: A Case Report.pubmed.ncbi.nlm.nih.gov
  6. Contemporary management pathways in liver trauma: predominant and successful use of non-operative strategies at a high-volume tertiary center.pubmed.ncbi.nlm.nih.gov
  7. Washout on Contrast-Enhanced Ultrasound of Benign Focal Liver Lesions-A Review on Its Frequency and Possible Causes.pubmed.ncbi.nlm.nih.gov
  8. A case of hepatic segmental atrophy mimicking spontaneously necrotized hepatocellular carcinoma.pubmed.ncbi.nlm.nih.gov
  9. CT and MRI imaging and interpretation of hepatic arterioportal shunts.pubmed.ncbi.nlm.nih.gov
  10. Imaging findings of mimickers of hepatocellular carcinoma.pubmed.ncbi.nlm.nih.gov
  11. Assessing Pancreatic Enhancement Variability in ICU Patients with CT Hypoperfusion Complex: A Retrospective Single-Center Study.pubmed.ncbi.nlm.nih.gov
  12. Case Report: Multimodality imaging features and serial metabolic changes on <sup>18</sup> F-FDG PET/CT in a dog with granulomatous hepatitis.pubmed.ncbi.nlm.nih.gov
  13. Ethnic-specific ZJU index thresholds for hepatic steatosis and fibrosis in Chinese MASLD.pubmed.ncbi.nlm.nih.gov
  14. Cardiac Surgery Management in Patients With Liver Cirrhosis.pubmed.ncbi.nlm.nih.gov
  15. Longitudinal Inpatient Trajectories After Splenic Artery Embolization in Cirrhosis: Real-World Evidence from Kazakhstan.pubmed.ncbi.nlm.nih.gov
  16. When Cancer Clots: An Extensive Radiologic Analysis of Cancer-Associated Thromboembolism.pubmed.ncbi.nlm.nih.gov
  17. Contrast-Enhanced CT Finding of Hot Spot Sign Secondary to Supra Hilar Mass Causing Superior Vena Cava Syndrome: A Case Report.pubmed.ncbi.nlm.nih.gov
  18. Liver Imaging Reporting and Data System (LI-RADS): A Comprehensive Review.pubmed.ncbi.nlm.nih.gov
  19. All About Multiparametric MRI Evaluation in Biliary Tree Complications After Liver Transplant.pubmed.ncbi.nlm.nih.gov
  20. Pilot study of an arterial enhancement fraction-based model for progression prediction in HCC undergoing chemoembolization.pubmed.ncbi.nlm.nih.gov
  21. Contrast-enhanced ultrasonography as a method of monitoring focal liver lesions - initial report.pubmed.ncbi.nlm.nih.gov
  22. Microengineering the Liver: Strategies for Constructing Functional Liver-on-a-Chip Devices.pubmed.ncbi.nlm.nih.gov
  23. Multi-modal AI for opportunistic screening, staging and progression risk stratification of steatotic liver disease.pubmed.ncbi.nlm.nih.gov
  24. Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and Protein-Losing Enteropathy.pubmed.ncbi.nlm.nih.gov
  25. Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists.pubmed.ncbi.nlm.nih.gov
  26. Multimodal imaging features to diagnose abdominal complications of sickle cell disease.pubmed.ncbi.nlm.nih.gov
  27. Contrast-enhanced ultrasound in the evaluation and management of solid renal lesions based on EFSUMB guidelines.pubmed.ncbi.nlm.nih.gov
  28. Non-contrast microvascular flow imaging in abdominal ultrasound: a pictorial essay.pubmed.ncbi.nlm.nih.gov
  29. Interventional, surgical, and clinical management of Abernethy malformations: A case series and novel anatomic variant.pubmed.ncbi.nlm.nih.gov
  30. A One-Dimensional (1D) Computational Fluid Dynamics Study of Fontan-Associated Liver Disease (FALD).pubmed.ncbi.nlm.nih.gov
  31. Delayed hepatic artery pseudoaneurysm with arterioportal fistula after penetrating liver trauma successfully treated with coil embolization: a case report and focused literature review.pubmed.ncbi.nlm.nih.gov
  32. Restoration of hepatopetal portal flow in a cat with left hepatic arteriovenous malformation following left hepatic division resection and staged attenuation of acquired portosystemic shunts.pubmed.ncbi.nlm.nih.gov
  33. Splenic Artery Aneurysm With Arterioportal Fistula: An Unusual Cause of Portal Hypertension.pubmed.ncbi.nlm.nih.gov
  34. Adult Hepatic Infarction for Internists: A Practical Diagnostic and Management Pathway to Avoid Misdiagnosis, Unnecessary Drainage, and Delayed Vascular Recognition.pubmed.ncbi.nlm.nih.gov
  35. Gun-sight technique for recanalization of chronic noncirrhotic, nonmalignant extrahepatic portal vein obstruction.pubmed.ncbi.nlm.nih.gov
  36. Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis.pubmed.ncbi.nlm.nih.gov
  37. Torsion of a pedunculated accessory hepatic lobe: Cross-sectional imaging and histopathological correlation.pubmed.ncbi.nlm.nih.gov
  38. Case Report: Hypervascular lipid-rich intrahepatic adrenocortical adenoma in the right posterior liver: a diagnostic challenge for hepatobiliary surgeons.pubmed.ncbi.nlm.nih.gov
  39. Dual-modality imaging with CEUS and MRI for early recurrence assessment in hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization.pubmed.ncbi.nlm.nih.gov
  40. Contrast-Enhanced Low-Mechanical-Index Endoscopic Ultrasound for the Evaluation of Focal Liver Lesions.pubmed.ncbi.nlm.nih.gov
  41. DEB-TACE Combined with Immunotherapy and Targeted Therapy for Advanced Hepatocellular Carcinoma with Scapular Metastasis: A Case Report.pubmed.ncbi.nlm.nih.gov
  42. Imaging Characterization of a Cystic Duct Neuroendocrine Carcinoma in a Dog Using Contrast-Enhanced Ultrasonography and Multiphasic Computed Tomography.pubmed.ncbi.nlm.nih.gov
  43. Hepatic Adrenal Rest Tumour (HART) Preoperatively Diagnosed as Hepatocellular Carcinoma in a Patient With Chronic Hepatitis B: Radiological Similarities in Lesions.pubmed.ncbi.nlm.nih.gov
  44. Fulminant emphysematous hepatitis with pneumoperitoneum: A case report.pubmed.ncbi.nlm.nih.gov
  45. Imaging after Pancreaticoduodenectomy: How Can the Radiologist Help the Surgeon.pubmed.ncbi.nlm.nih.gov
  46. Computed tomography of pediatric abdominal trauma: optimizing utilization and enhancing diagnostic interpretation.pubmed.ncbi.nlm.nih.gov
  47. Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond.pubmed.ncbi.nlm.nih.gov
  48. Association of metabolic dysfunction-associated fatty liver disease with coronary CT angiography-derived plaque characteristics and cardiovascular events.pubmed.ncbi.nlm.nih.gov
  49. Focal Hyperechoic Hepatic Lesions in Northern Region of Saudi Arabia: Prevalence, Radiologic Features, and Clinical Relevance.pubmed.ncbi.nlm.nih.gov
  50. Single-center experience of interventional therapy for congenital portal-systemic shunt in children.pubmed.ncbi.nlm.nih.gov
  51. Acute portal vein thrombosis postimage-guided liver biopsy in common variable immunodeficiency.pubmed.ncbi.nlm.nih.gov
  52. Pseudotumoral portal cavernoma mimicking hilar cholangiocarcinoma: A diagnostic pitfall.pubmed.ncbi.nlm.nih.gov
  53. A Retrospective Study of Ultrasonographic Features of Hepatic Metastases Following Adrenal Cortical Carcinoma Resection.pubmed.ncbi.nlm.nih.gov
  54. Diagnostic challenges in hepatic metastatic olfactory neuroblastoma: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  55. Role of liver transient elastography in detecting cirrhosis with esophageal and gastric varices and evaluating variceal severity.pubmed.ncbi.nlm.nih.gov
  56. Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells.pubmed.ncbi.nlm.nih.gov
  57. Unveiling the Spectrum of Liver Endurance in Systemic Lupus Erythematosus: A Single-Center Experience From Kashmir, India.pubmed.ncbi.nlm.nih.gov
  58. Ultrasound Evaluation of Fontan-Associated Liver Disease: A State-of-the-Art Review.pubmed.ncbi.nlm.nih.gov
  59. A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced CT and respiration-tracked 4D-CT for radiotherapy targeting.pubmed.ncbi.nlm.nih.gov
  60. Hepatobiliary phase imaging in HCC: revisiting diagnostic algorithms and clinical utility of gadoxetic acid-enhanced MRI across international guidelines.pubmed.ncbi.nlm.nih.gov
  61. The characteristics of liver nodules in biliary atresia native liver survivors.pubmed.ncbi.nlm.nih.gov
  62. Bleeding Stomal Varices and Vascular Interventional Radiology Management: A Case Report.pubmed.ncbi.nlm.nih.gov
  63. Rescue transsplenic thrombectomy for portal remnant thrombosis after ALPPS stage 1.pubmed.ncbi.nlm.nih.gov
  64. Transabdominal Ultrasound-guided Transjugular Endovascular Mesocaval Shunt Creation in Extrahepatic Portal Vein Obstruction: A Single-center Experience.pubmed.ncbi.nlm.nih.gov
  65. EAT Thickness and BAT-Related Thermogenesis: Dual Imaging Phenotypes Associated with Hepatic Steatosis Severity in MASLD.pubmed.ncbi.nlm.nih.gov
  66. Biochemical-Anthropometric Indices Assessing Liver Steatosis Identified in Elastography in Children with Metabolic DysFunction-Associated Steatotic Liver Disease.pubmed.ncbi.nlm.nih.gov
  67. The Role of CEUS in the Diagnosis and Follow-Up of Pleuropulmonary Diseases and Interventional Procedures.pubmed.ncbi.nlm.nih.gov
  68. Understanding Photon-Counting CT: Physics, Detector Technology, and Image Reconstructions.pubmed.ncbi.nlm.nih.gov
  69. Dual-low spectral CT pulmonary angiography: a comparative study of image quality, radiation dose, and iodine intake with evaluation of pulmonary embolism detection.pubmed.ncbi.nlm.nih.gov
  70. Lysyl oxidase (LOX) family proteins in extracellular matrix homeostasis: roles in disease and radiation-induced pathogenesis.pubmed.ncbi.nlm.nih.gov
  71. Metabolic Regulation of Macrophages in Health and Disease.pubmed.ncbi.nlm.nih.gov
  72. TGF-beta inhibitors in cancer therapy: a review of the TGF-beta signal transduction pathway and current developments.pubmed.ncbi.nlm.nih.gov
  73. DNA-based characterization of primary hepatic MALT lymphoma reveals a rare FAT3 missense variant and Hippo pathway activation: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  74. Underlying thrombotic conditions in patients with splenic infarction: a 10-year retrospective analysis.pubmed.ncbi.nlm.nih.gov
  75. Splenic infarction after endoscopic glue injection for gastric varices: proportion, exploratory correlates, and clinical outcomes from a propensity score-matched analysis.pubmed.ncbi.nlm.nih.gov
  76. Contrast-enhanced ultrasound of the small organs in children.pubmed.ncbi.nlm.nih.gov
  77. Acute mesenteric ischaemia: a pictorial review.pubmed.ncbi.nlm.nih.gov
  78. Case Report: Focal nodular hyperplasia of the liver in an adolescent-a case report and literature review.pubmed.ncbi.nlm.nih.gov
  79. Depicting Characteristic Staghorn Vessels in Solitary Fibrous Tumor of the Liver With Contrast-Enhanced Ultrasound and Ultrasound Localized Microscopy: A Case Report.pubmed.ncbi.nlm.nih.gov
  80. Case Report: Indocyanine green fluorescence imaging in complex focal nodular hyperplasia resection: report of two cases.pubmed.ncbi.nlm.nih.gov
  81. Computed Tomographic Findings of Liver Cirrhosis in Dogs: Comparison between Compensated and Decompensated Cirrhosis.pubmed.ncbi.nlm.nih.gov
  82. The Gastric Vein Variants: An Evidence-Based Systematic Review of Prevalence and Clinical Considerations.pubmed.ncbi.nlm.nih.gov
  83. Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.pubmed.ncbi.nlm.nih.gov
  84. Transient hepatic attenuation difference or fat sparing? Aberrant right gastric vein determining a pseudolesion at the border of the IInd/IIIrd liver segments. Review of developmental concepts.pubmed.ncbi.nlm.nih.gov
  85. Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics.pubmed.ncbi.nlm.nih.gov
  86. HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis.pubmed.ncbi.nlm.nih.gov
  87. Society for Cardiovascular Magnetic Resonance 2024 Cases of SCMR case series.pubmed.ncbi.nlm.nih.gov
  88. Benign and malignant focal liver lesions displaying rim arterial phase hyperenhancement on CT and MRI.pubmed.ncbi.nlm.nih.gov
  89. Computed Tomographic Findings in Dogs with Hepatic Bacterial Parenchymal Infection and Abscessation.pubmed.ncbi.nlm.nih.gov
  90. Comprehensive review of pulmonary embolism imaging: past, present and future innovations in computed tomography (CT) and other diagnostic techniques.pubmed.ncbi.nlm.nih.gov
  91. A Diagnostic Dilemma in Hepatic Cystic Lesions: Radiological Mimicry of Biliary Cystadenoma and Hydatid Cyst in a Histologically Confirmed Simple Hepatic Cyst.pubmed.ncbi.nlm.nih.gov
  92. Obesity and Cardiovascular Disease: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2026.pubmed.ncbi.nlm.nih.gov
  93. Septic Pylephlebitis and Cavernous Transformation Presenting as Pyrexia of Unknown Origin: A Diagnostic Challenge.pubmed.ncbi.nlm.nih.gov
  94. Computed tomography of renal emergencies: A comprehensive diagnostic guide for radiology residents.pubmed.ncbi.nlm.nih.gov
  95. Anatomy of the intraosseous arterial microvasculature of the adult lumbar vertebral body and its role in fracture healing: a literature review and historical perspective.pubmed.ncbi.nlm.nih.gov
  96. Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma.pubmed.ncbi.nlm.nih.gov
  97. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.pubmed.ncbi.nlm.nih.gov
  98. Computed Tomographic Findings and Clinical Manifestations of Acute Severe Hypersensitivity to a Non-Ionic Iodinated Contrast Agent in a Castrated Male Dog: A Case Report.pubmed.ncbi.nlm.nih.gov
  99. Comparing the computed tomography radiologic features of cytokeratin 19-positive hepatocellular carcinoma to those of conventional hepatocellular carcinoma and intrahepatic cholangiocarcinoma.pubmed.ncbi.nlm.nih.gov
  100. Quercetin as a Multifunctional Flavonol: Molecular Insights and Therapeutic Applications.pubmed.ncbi.nlm.nih.gov
  101. Dissecting myocardial and systemic drivers of cardiac dysfunction in the murine CVB3 myocarditis model using microRNA-guided viral detargeting.pubmed.ncbi.nlm.nih.gov
  102. Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions.pubmed.ncbi.nlm.nih.gov
  103. Amphiphile Blending Controls Micelle Morphology to Enhance <i>In Vitro</i> Performance and Selective <i>In Vivo</i> mRNA Delivery to Lung and Spleen.pubmed.ncbi.nlm.nih.gov
  104. Cosmic Signs in Radiology: A Pictorial Review.pubmed.ncbi.nlm.nih.gov
  105. Endocytosis-independent cytosolic entry of messenger RNA via fluorous bilayer zippering attenuating Toll-like receptor signaling and enables ischemic tissue salvage.pubmed.ncbi.nlm.nih.gov
  106. Sensory spinal interoceptive pathways and energy balance regulation.pubmed.ncbi.nlm.nih.gov
  107. FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study.pubmed.ncbi.nlm.nih.gov
  108. Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review.pubmed.ncbi.nlm.nih.gov
  109. Hepatic mesenchymal hamartoma showing hepatobiliary-phase signal increase on gadoxetate disodium-enhanced magnetic resonance imaging: A case report.pubmed.ncbi.nlm.nih.gov
  110. Biomedical Materials and Fabrication Methods for Construction of In Vitro Neurovascular Unit Models.pubmed.ncbi.nlm.nih.gov
  111. Immunometabolism in Obesity-Associated Type 2 Diabetes: Molecular Mechanisms and Emerging Therapeutic Targets.pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.